Efficacy of Cannabinoids in a Pre-Clinical Drug-Screening Platform for Alzheimer’s Disease

Penicillin celebrated its 90th anniversary last year. The story of the mold extract’s accidental discovery is legendary, taught in schools and touted in labs. In 1890, acetylsalicylic acid, commonly known as Aspirin, was synthetically modeled after its naturally occurring counterpart found in such common plants as birch, wintergreen, and willow. Medicine has benefited from nature […]

Rock Climbing

I have a stressful life. I know I’m not the only one, and I advocate strongly for anyone whose lives are heaped with stress to take care of themselves. Charlotte’s first five years were hellish for us all. She was so sick. As a parent, it was sometimes necessary to put myself second for the […]

Backstory: Part I

I have three different ways I introduce myself. When I’m at work, I am the chief development officer of Subway. When I’m at an AA meeting, I am an alcoholic. And when I’m speaking in forums about my recovery outside of AA, I am a person in long-term recovery. For many people, cannabis and alcohol […]

Ep. 459: Dr. Ethan Russo

Dr. Ethan Russo, Research Director of the International Cannabis and Cannabinoids Institute (ICCI), discusses ways to create a better, safer cannabis. Russo points out the dissonance that exists between public opinion and regulators – while 80-90% of the public already believes that cannabis is a medicine, the medical community must conduct clinical trials in order […]

Post-Show Report: Digital Workshop 7/30-7/31

Cannabis Economy Digital Workshop Post-Show Report  The initial Cannabis Economy Digital Workshop took place July 30-31, 2019. Each day we had 15 straight hours of content resulting in 38 sessions from Science, Policy and Business leaders. Thank you to our presenters, partners and sponsors for making the event such a success. Whether or not you […]

Cannabinoid Report: THC 101

Many people can tell you that they’ve at least heard of THC, but most would struggle to thoroughly describe it. Indeed, THC is famous for a good reason: it is cannabis’s primary psychoactive component and was the first cannabinoid to be discovered by modern scientists (in 1964 by Dr. Raphael Mechoulam at the Weizmann Institute […]

Ep. 454: Catherine Sandvos, The Netherlands

Catherine Sandvos, of the Office of Medicinal Cannabis in the Netherlands, joins us to discuss the history and current state of Dutch cannabis regulations. Sandvos is pleased that other countries seem to be setting up their own regulations and production processes, as it relieves the Netherlands of the responsibility to provide for all of Europe. […]

Ep. 453: Don Fertman

Another great conversation with Don Fertman as he shares stories about his past struggles with alcohol addiction, providing a framework to talk about cannabis, addiction, and moderation: “I got myself together and got myself to work, but now I felt like even more of a failure. My self-loathing, my self-hatred, my sense of disgust with […]

Ep. 448: Charlie Bachtell, Cresco Labs

Charlie Bachtell joins us and shares how Cresco Labs and other medical cannabis providers have to adapt to pass regulation audits: “The objectives of the state are to make sure that you are tracking everything from seed to sale, that you are putting out as consistent and safe of a product as you, possibly, can, […]

Q2 Column Highlights

Q2 Column Highlights:   Biography – Dr. Sharon Sznitman Everyone can learn from the sociological angle. But a sense of alienation makes it possible to discern more clearly how society shapes our personal lives. Instead of looking only at the possible damage from using cannabis, scientists are now examining the benefits of using it. A […]